HUE054161T2 - Megnövelt stabilitású és javított abszorpciójú honokiol és magnolol készítmények és ezek alkalmazása - Google Patents

Megnövelt stabilitású és javított abszorpciójú honokiol és magnolol készítmények és ezek alkalmazása

Info

Publication number
HUE054161T2
HUE054161T2 HUE16836765A HUE16836765A HUE054161T2 HU E054161 T2 HUE054161 T2 HU E054161T2 HU E16836765 A HUE16836765 A HU E16836765A HU E16836765 A HUE16836765 A HU E16836765A HU E054161 T2 HUE054161 T2 HU E054161T2
Authority
HU
Hungary
Prior art keywords
magnolol
honokiol
formulations
increased stability
improved absorption
Prior art date
Application number
HUE16836765A
Other languages
English (en)
Hungarian (hu)
Inventor
Bomi P Framroze
Original Assignee
St Ip Holding Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Ip Holding Ag filed Critical St Ip Holding Ag
Publication of HUE054161T2 publication Critical patent/HUE054161T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/60Fish, e.g. seahorses; Fish eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/57Magnoliaceae (Magnolia family)
    • A61K36/575Magnolia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUE16836765A 2015-08-17 2016-01-18 Megnövelt stabilitású és javított abszorpciójú honokiol és magnolol készítmények és ezek alkalmazása HUE054161T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2534DE2015 2015-08-17

Publications (1)

Publication Number Publication Date
HUE054161T2 true HUE054161T2 (hu) 2021-08-30

Family

ID=58051448

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE16836765A HUE054161T2 (hu) 2015-08-17 2016-01-18 Megnövelt stabilitású és javított abszorpciójú honokiol és magnolol készítmények és ezek alkalmazása

Country Status (12)

Country Link
US (1) US10328090B2 (enExample)
EP (1) EP3337487B1 (enExample)
JP (1) JP6663993B2 (enExample)
KR (1) KR20180050331A (enExample)
AU (2) AU2016308080A1 (enExample)
CA (1) CA2995834A1 (enExample)
DK (1) DK3337487T3 (enExample)
ES (1) ES2873601T3 (enExample)
HU (1) HUE054161T2 (enExample)
PL (1) PL3337487T3 (enExample)
PT (1) PT3337487T (enExample)
WO (1) WO2017029683A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019183141A1 (en) 2018-03-21 2019-09-26 Realtime Robotics, Inc. Motion planning of a robot for various environments and tasks and improved operation of same
KR20200083304A (ko) * 2018-12-28 2020-07-08 충북대학교 산학협력단 일본 목련 추출물을 유효성분으로 함유하는 불안장애의 예방 또는 치료용 약학적 조성물
WO2020154712A1 (en) * 2019-01-25 2020-07-30 Flaask, Llc Compositions and methods for improving quality of life in patients with autism spectrum disorder
CN110585140A (zh) * 2019-07-08 2019-12-20 苏州海特比奥生物技术有限公司 一种和厚朴酚纳米聚合物胶束冻干制剂及其制备方法
US12213505B2 (en) * 2021-07-05 2025-02-04 Healthy Ingredient Solutions, LLC Composition for promoting restful sleep and methods of making and using the same
WO2025136962A1 (en) * 2023-12-19 2025-06-26 Rebalance Health, Inc. Compositions for reducing hot flashes and symptoms associated with anxiety and formulations thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582735B2 (en) 2000-12-15 2003-06-24 Npi, Llc. Compositions and methods of use for extracts of magnoliaceae plants
US7632525B2 (en) 2002-06-25 2009-12-15 Wm. Wrigley Jr. Company Breath freshening and oral cleansing product with magnolia bark extract in combination with surface active agents
CN1723011A (zh) 2002-06-25 2006-01-18 Wm·雷格利Jr·公司 含有厚朴提取物的口气清新和口腔清洁产品
CN101321537A (zh) 2005-12-02 2008-12-10 Gic创新公司 含厚朴提取物的糖食组合物
RU2396941C2 (ru) 2005-12-02 2010-08-20 Джи Ай Си ИННОВАТИОНЗ КОМПАНИ Наполнители с экстрактом коры магнолии для ухода за полостью рта
RU2398593C2 (ru) 2005-12-02 2010-09-10 Джи Ай Си ИННОВАТИОНЗ КОМПАНИ Жевательные составы с экстрактом коры магнолии быстрого высвобождения
BRPI0810435A2 (pt) 2007-04-19 2014-11-25 Mary Kay Inc Composições contendo extrato de magnólia
WO2011115476A1 (en) * 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
DE102010015791A1 (de) * 2010-04-20 2011-10-20 Beiersdorf Ag Wirkstoffkombinationen aus Magnolienrindenextrakt und polyethoxylierten Verbindungen
DE102010015792A1 (de) * 2010-04-20 2011-10-20 Beiersdorf Ag Wirkstoffkombinationen aus Magnolienrindenextrakt und oberflächenaktiven Agentien
EP2611313A1 (en) * 2010-09-03 2013-07-10 N.V. Nutricia Method and preparation for the treatment or prevention of anxiety or neurogenesis
FR2970294B1 (fr) * 2011-01-11 2012-12-28 Peugeot Citroen Automobiles Sa Ligne d'echappement pour un moteur a combustion interne
IE20110008A1 (en) 2011-01-12 2012-08-01 Patrick Thomas Prendergast Compositions for alleviating:- stress, anxiety, depression and aiding with weight loss
WO2013043151A1 (en) 2011-09-19 2013-03-28 Framroze Bomi P Edible oil with a high concentration of poly-unsaturated fatty acids
CA2849294C (en) * 2011-09-20 2023-03-21 Vivaquant Llc Physiological signal denoising

Also Published As

Publication number Publication date
PT3337487T (pt) 2021-05-27
WO2017029683A1 (en) 2017-02-23
KR20180050331A (ko) 2018-05-14
US20180147220A1 (en) 2018-05-31
JP6663993B2 (ja) 2020-03-13
EP3337487B1 (en) 2021-02-24
EP3337487A4 (en) 2019-04-03
DK3337487T3 (da) 2021-05-25
JP2018528266A (ja) 2018-09-27
US10328090B2 (en) 2019-06-25
AU2016308080A1 (en) 2018-03-22
PL3337487T3 (pl) 2021-12-06
EP3337487A1 (en) 2018-06-27
ES2873601T3 (es) 2021-11-03
AU2022201271A1 (en) 2022-03-17
CA2995834A1 (en) 2017-02-23

Similar Documents

Publication Publication Date Title
HUE054103T2 (hu) Izokinolin-3-il-karboxamidok, ezek elõállítása és alkalmazása
HUE055755T2 (hu) Szulfonolkarmabidok és rokon vegyületeik valamint felhasználásuk
BR112016021626A2 (pt) indazol-3-carboxamidas 5-substituídas e preparação e uso das mesmas
HUE061253T2 (hu) Antitestek OX40 ellen és azok felhasználásai
BR112016030787A2 (pt) entidade química, composição farmacêutica e seu uso
AR094502A1 (es) Pirazoles sustituidos en posicion 3 y usos de los mismos
HUE057607T2 (hu) Pirazol-pirimidin-származék és annak felhasználása
HUE056167T2 (hu) Roseburia flagellin és immun-moduláció
BR112016030968A2 (pt) análogos de pridopidina, preparação e uso destes
HUE042800T2 (hu) 1,2,4-triazolok mint nukleáris transzport modulátorok és ezek alkalmazása
HUE034927T2 (hu) Szilícium gél kompozíció és ennek alkalmazása
HUE072128T2 (hu) Hagyományos kínai gyógyászati összetétel, és annak elõállítása és alkalmazása
CL2016002569A1 (es) Anticuerpos, composiciones farmacéuticas y usos de los mismos
CL2014003612S1 (es) Peine para aparato de aseo
FR3003568B1 (fr) Composition comprenant hf et 3,3,3-trifluoro-2-chloropropene
HUE057365T2 (hu) Triciklusos benzoxaborol vegyületek és felhasználásuk
HUE061179T2 (hu) Szárító kompozíció és alkalmazása
HUE047460T2 (hu) Szubsztituált 4-azaindolok és ezek alkalmazása mint GLUN2B receptor modulátorok
DK2961835T3 (da) Ny bakteriophag og antibakteriel sammensætning omfattende samme
HUE053033T2 (hu) Hidrolázoknak ellenálló kapszidokat alkalmazó készítmények és eljárások
HUE054161T2 (hu) Megnövelt stabilitású és javított abszorpciójú honokiol és magnolol készítmények és ezek alkalmazása
HUE046033T2 (hu) Új kriptoficin vegyületek és konjugátumok, elõállításuk és gyógyászati alkalmazásuk
HUE055020T2 (hu) Prosztata-antigén szabványok és azok felhasználása
BR112016027379A2 (pt) formulações tópicas e seus usos
HUE055282T2 (hu) TATK-CDKL5 fúziós fehérjék, készítmények, formulák és azok alkalmazása